Surface Plasmon Resonance Market Size was valued at USD 1.10 Billion in 2022. The surface plasmon resonance industry is projected to grow from USD 1.17 Billion in 2023 to USD 1.99 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2023 - 2032). Increasing demand for drug discovery & development and rising adoption of personalized medicine are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR is anticipated to surge due to robust investment in pharmaceutical research and development. The surface plasmon resonance market is experiencing a significant surge in growth, largely propelled by the escalating demand within the realm of drug discovery and development. This burgeoning demand is intricately linked to the indispensable role that SPR technology plays in revolutionizing the processes fundamental to pharmaceutical research. In the pursuit of novel therapeutics, the ability to swiftly and accurately analyze bimolecular interactions is paramount. Herein lies the allure of SPR systems, which offer a unique blend of real-time monitoring and label-free detection, facilitating a deeper understanding of molecular binding events crucial to drug discovery. This capability not only expedites the identification and validation of potential drug candidates but also enhances the efficiency of lead optimization efforts, thereby streamlining the overall drug development pipeline.
Moreover, as the pharmaceutical landscape evolves, with a marked emphasis on precision medicine and targeted therapies, the need for sophisticated analytical tools becomes increasingly pronounced. SPR technology emerges as a cornerstone in this paradigm shift, enabling researchers to unravel the intricate complexities of molecular interactions with unprecedented accuracy. By facilitating the characterization of biomarkers, elucidation of binding kinetics, and assessment of drug-target interactions, SPR systems empower pharmaceutical scientists to make more informed decisions, driving innovation in therapeutic development.
Furthermore, the intensifying competition within the pharmaceutical industry underscores the imperative for differentiation and efficiency. In this context, SPR technology emerges as a compelling asset, offering a competitive edge through its ability to accelerate the drug discovery process while minimizing costs and resource utilization. By providing valuable insights into the efficacy, specificity, and pharmacokinetic properties of candidate compounds, SPR systems enable pharmaceutical companies to make strategic decisions at every stage of drug development, ultimately enhancing their chances of success in a fiercely competitive market landscape.
For instance, in April 2023, Malvern Panalytical Taiwan opened a new state-of-the-art applications lab. This facility stands as a substantial investment, exceeding USD 1 million. This new space is dedicated to fostering innovation and providing high-quality solutions, solidifying its position as a key player in the analytical instrumentation sector. Thus, such investments in the industry is driving the surface plasmon resonance market revenue.
The surface plasmon resonance market segmentation, based on product type includes imaging system, sensor system, and reagents. The imaging system segment dominated the market, accounting for 46% of market revenue (0.51 Billion). The rising demand for real-time visualization of molecular interactions, driving research efficiency and facilitating rapid drug discovery processes. Additionally, advancements in imaging technology offer enhanced sensitivity and resolution, further fueling adoption.
Figure 1: Surface plasmon resonance Market, by Product Type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The surface plasmon resonance market segmentation, based on application, includes drug discovery, material science, and biosensors. The drug discovery category generated the most income (58%). The rising demand for accurate and rapid analysis of bimolecular interactions, expediting the identification and optimization of potential therapeutic candidates. Furthermore, as pharmaceutical companies intensify their efforts to develop innovative treatments, the versatility and efficiency of SPR technology become increasingly indispensable, driving market growth.
The surface plasmon resonance market segmentation, based on end user, includes academic & research institutes, food & beverage industry, biopharmaceutical companies, CROs, and others. The biopharmaceutical companies’ category generated the most income (43%). The sales is poised to grow due to critical role of SPR technology, plays in expediting drug development processes, enhancing research efficiency, and ensuring the quality of therapeutic candidates. Additionally, as the demand for precision medicine and targeted therapies rises, biopharmaceutical firms increasingly rely on SPR systems for accurate molecular analysis, further driving market expansion.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American surface plasmon resonance market area will dominate this market, due to the region's robust pharmaceutical and biotechnology sectors, coupled with substantial investments in research and development, driving demand for advanced analytical technologies like SPR.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: SURFACE PLASMON RESONANCE MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe surface plasmon resonance market accounts for the second-largest market share owing to stringent regulations promoting drug development, along with a strong presence of academic and research institutes fostering innovation and driving the adoption of SPR technology for various applications. Further, the German surface plasmon resonance market held the largest market share, and the UK surface plasmon resonance market was the fastest growing market in the European region
The Asia-Pacific surface plasmon resonance market is expected to grow at the fastest CAGR from 2023 to 2032. The Asia-Pacific region is witnessing a surge in the sales of surface plasmon resonance due to rapid industrialization, increasing investment in healthcare infrastructure, and rising demand for personalized medicine. Moreover, China’s surface plasmon resonance market held the largest market share, and the Indian surface plasmon resonance market was the fastest growing market in the Asia-Pacific region.
Leading market players continuously strive to enhance their product offerings and expand their market presence. These key players employ strategies such as mergers and acquisitions, partnerships, and product launches to maintain their competitive edge and cater to evolving customer needs. Market developments, including technological advancements and innovations in SPR systems, play a crucial role in shaping the competitive dynamics of the industry.
In the surface plasmon resonance industry, competition among key players remains intense as they vie for market share and leadership positions. The evolving regulatory landscape and increasing demand for high-throughput screening and analysis solutions present both challenges and opportunities for players in the surface plasmon resonance industry. To stay ahead in this dynamic market, industry participants are focusing on product innovation, geographic expansion, and strategic collaborations to strengthen their competitive position and capitalize on emerging trends. Major players in the surface plasmon resonance market, including GE Healthcare, AMETEK.Inc., Horiba, Bio-Rad Laboratories, Inc. and others, are attempting to increase market demand by investing in research and development operations.
GE Healthcare is a prominent player in the surface plasmon resonance market, offering innovative solutions for drug discovery and development. With a rich history of technological expertise, GE Healthcare's SPR systems deliver exceptional performance, accuracy, and reliability. The company's comprehensive portfolio includes advanced imaging and sensor systems, as well as high-quality reagents, catering to the diverse needs of pharmaceutical researchers and biotech professionals worldwide. Backed by a commitment to research and development, GE Healthcare continues to drive market advancements and address evolving customer demands, solidifying its position as a leading provider of SPR technology.
AMETEK, Inc. is a trusted name in the surface plasmon resonance industry, renowned for its cutting-edge sensor systems and analytical instrumentation. With a focus on precision engineering and innovation, AMETEK's SPR solutions deliver unparalleled sensitivity, versatility, and performance. The company's diverse product portfolio encompasses state-of-the-art imaging systems, sensor arrays, and reagents, empowering researchers and scientists to accelerate drug discovery and biomedical research. AMETEK's unwavering commitment to excellence, coupled with its presence and customer-centric approach, positions it as a preferred partner for biopharmaceutical companies, academic institutions, and research laboratories seeking advanced SPR technology solutions.
GE Healthcare
AMETEK.Inc.
Bio-Rad Laboratories, Inc.
Bristol Myers Squibb
Bruker
Biosensing Instrument Inc.
Malvern Panalytical
Reichert Technologies
January 2023: GE Healthcare witnessed the separation from GE, culminating in the launch of GE HealthCare Technologies Inc. This successful spin-off signals a significant milestone in the company’s journey towards three independent entities, each dedicated to thriving sectors.
February 2023: Horiba Techno Service finalized the construction of its new head office building, marking a significant step in bolstering and broadening its service business globally. The expansion includes an enlarged analysis laboratory, now serving as the analytical solution plaza, doubling as a capacity.
Imaging System
Sensor System
Reagents
Drug Discovery
Material Science
Biosensors
Academic & Research Institutes
Food & Beverage Industry
Biopharmaceutical Companies
CROs
Others
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.10 Billion |
| Market Size 2023 | USD 1.17 Billion |
| Market Size 2032 | USD 1.99 Billion |
| Compound Annual Growth Rate (CAGR) | 6.80% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Application Type, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | GE Healthcare, AMETEK.Inc., Horiba, Bio-Rad Laboratories, Inc., Carterra Inc., Bristol Myers Squibb, Bruker, Biosensing Instrument Inc., Malvern Panalytical, and Reichert Technologies |
| Key Market Opportunities | Rising adoption of personalized medicine and expansion of life sciences research |
| Key Market Dynamics | Increasing focus on point-of-care testing and technological advancements |
Surface Plasmon Resonance Market Highlights:
Frequently Asked Questions (FAQ) :
The Surface plasmon resonance market size was valued at USD 1.10 Billion in 2022.
The market is projected to grow at a CAGR of 6.80% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are GE Healthcare, AMETEK.Inc., Horiba, Bio-Rad Laboratories, Inc., Carterra Inc., Bristol Myers Squibb, Bruker, Biosensing Instrument Inc., Malvern Panalytical, and Reichert Technologies.
The imaging system category dominated the market in 2022.
The drug discovery had the largest share in the market.
Team Lead - Research Anshula mandaokar holds an academic degree in chemical engineering and has been contributing to the field for more than 5 years. she has expertise in market research and business consulting and serves as a team lead for a reputed market research firm under the chemicals and materials domain spectrum. she has worked on multiple projects, generating explicit results in a quick turnaround time. her understanding of data interpretation justifies her role as a leader.
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
